DR. JOHN THACHIL MD NPI 1710920160

NPI Information

  • NPI: 1710920160
  • Provider Name: DR. JOHN THACHIL, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 13300 HARGRAVE RD
    STE 190
    HOUSTON, TX
    ZIP 77070
  • Phone: (281) 332-7505

Map and Directions

Get Directions

NPI Details

DR. John Thachil, MD is a hematology and oncology internal medicine in Houston, TX with 44 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. John Thachil, MD NPI is 1710920160. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

13300 HARGRAVE RD
STE 190
HOUSTON, TX
ZIP 77070-379
Phone: (281) 332-7505
Fax: (281) 897-1215

The NPI 1710920160 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Unclassified drugs (HCPCS:J3490)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)

The enumeration date for this NPI number is 6/14/2006 and was last updated on 11/14/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyK4588TEXASNo
2207RH0003XInternal MedicineHematology & OncologyK4588TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1129003306MEDICAIDTEXAS
2830004435MEDICARE PINTEXAS
3TXB126878MEDICARE PINTEXAS
4E24293MEDICARE UPINTEXAS
587894KMEDICARE PINTEXAS
680950JMEDICARE PINTEXAS
7TXB132412MEDICARE PINTEXAS
8129003307MEDICAIDTEXAS
9100064000AMEDICAIDOKLAHOMA
10129003305MEDICAIDTEXAS
118R1567OTHERTEXASBLUE CROSS OF TEXAS
12129003302MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.